Amarin Corporation
AMRN
$0.91
Share price
-0.87%
Change (1 day)
-33.58%
Change (1 year)
Categories
Amarin Corporation (AMRN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.27 B
According to Amarin Corporation 's latest financial reports the company's total liabilities are $0.27 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Amarin Corporation - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -3.87% |
| 2022-12-31 | $0.29 B | -27.46% |
| 2021-12-31 | $0.40 B | 18.45% |
| 2020-12-31 | $0.33 B | 23.57% |
| 2019-12-31 | $0.27 B | 17.38% |
| 2018-12-31 | $0.23 B | 2.95% |
| 2017-12-31 | $0.22 B | 28.76% |
| 2016-12-31 | $0.17 B | -41.47% |
| 2015-12-31 | $0.30 B | 15.88% |
| 2014-12-31 | $0.25 B | -9.35% |
| 2013-12-31 | $0.28 B | -9.06% |
| 2012-12-31 | $0.31 B | 137.91% |
| 2011-12-31 | $0.13 B | -44.33% |
| 2010-12-31 | $0.23 B | 386.69% |
| 2009-12-31 | $48.84 M | 529.55% |
| 2008-12-31 | $7.75 M | -57.14% |
| 2007-12-31 | $18.1 M | 64.73% |
| 2006-12-31 | $10.99 M | 34.36% |
| 2005-12-31 | $8.18 M | 16.39% |
| 2004-12-31 | $7.02 M | -86.92% |
| 2003-12-31 | $53.72 M | -48.22% |
| 2002-12-31 | $0.10 B | 69.17% |
| 2001-12-31 | $61.32 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | $124.31 B | 44,363.44% | 🇺🇸 USA |
 AstraZeneca AZN | $64.79 B | 23,074.18% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $58.82 B | 20,940.07% | 🇬🇧 UK |
 Alkermes ALKS | $0.93 B | 233.90% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 12,544.72% | 🇮🇱 Israel |